Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sage Therapeutics, Inc. (SAGE) and Encourages Stockholders to Learn More About the Investigation
Portfolio Pulse from
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of Sage Therapeutics, Inc. (NASDAQ:SAGE) investors who purchased securities before April 12, 2021. Investors are encouraged to learn more about the investigation.
February 02, 2025 | 3:15 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Sage Therapeutics, Inc. for investors who purchased securities before April 12, 2021. This could lead to legal challenges for the company.
The investigation by a law firm into potential claims against Sage Therapeutics could indicate legal troubles, which may negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100